Abstract PO4-20-11: Excellent Response to Trastuzumab Deruxtecan in “HER-2 Low” Leptomeningeal Breast Cancer and Diagnostic and Monitoring Utility of CNSide Assay
Department
Oncology and Hematology
Document Type
Conference Proceeding
Publication Title
Cancer Research
Conference Name
San Antonio Breast Cancer Symposium
Conference Date
2023-12-05 - 2023-12-09
First Page
PO4-20-11
DOI
10.1158/1538-7445.SABCS23-PO4-20-11
Volume
84
Issue
9_Supplement
Publication Date
5-1-2024
Recommended Citation
Stanford, S., Kharel, Z., Hemminger, L., Schmidt, T., Hardy, S., Zittel, J., Mohile, N., & Dhakal, A. (2024). Abstract PO4-20-11: Excellent Response to Trastuzumab Deruxtecan in “HER-2 Low” Leptomeningeal Breast Cancer and Diagnostic and Monitoring Utility of CNSide Assay. Cancer Research, 84 (9_Supplement), PO4-20-11. https://doi.org/10.1158/1538-7445.SABCS23-PO4-20-11
COinS